Skip to content

COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation

COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142932
Acronym
C2Q
Enrollment
102
Registered
2017-05-08
Start date
2017-05-17
Completion date
2017-11-30
Last updated
2019-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Cessation

Keywords

smoking

Brief summary

The objective of this study is to conduct a randomized controlled trial to determine whether the use of the COach2Quit application (app) reduces smoking more than brief advice for smoking cessation. The investigators hypothesize that real time biomarker feedback and messaging support from the COach2Quit app will lead to greater smoking cessation rates than brief anti-smoking advice alone. If effective, the COach2Quit app could be an easily accessible and cost-effective tool to help smokers quit. The findings from this trial could have implications for the delivery of future outpatient smoking cessation programs.

Detailed description

The goal of this randomized controlled trial is to assess the efficacy of the novel COach2Quit smartphone application by determining whether the use of this app reduces smoking more than brief anti-smoking advice alone. This will be a two-arm individually randomized trial and participants who are currently smoking will be assigned 1:1 to either study arm. Smoking behavior will be measured through self-report at baseline, 2-week and 1-month follow up visits. Smoking behavior will also be verified by 2 biomarker measurements: carbon monoxide breath test and urine cotinine, collected at baseline, 2-week and 1-month follow-up visits. In addition, participants will receive weekly follow-up calls. The primary outcome will be smoking cessation at the 1-month follow-up visit.

Interventions

DEVICEIndividualized carbon monoxide (iCO) monitor

a personal monitor for a breath test for carbon monoxide (CO)

OTHERCOach2Quit smartphone application

This smartphone application works in conjunction with the iCO monitor

The advice to quit smoking message will follow NCI's 5 A's model for smoking cessation counseling. This is a simple smoking cessation counseling strategy with 5 discrete components: (1) Ask about smoking at every opportunity; (2) Advise the patient to quit smoking; (3) Assess readiness to quit; (4) Assist the patient in quitting; and (5) Arrange follow-up.

Sponsors

Maryland Department of Health and Mental Hygiene
CollaboratorOTHER_GOV
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * current, daily smokers * agree to participate and anticipate to be living in Baltimore for at least 2 months * own a phone that is compatible with the app * be willing to set at baseline assessment a quit date within 2 weeks

Exclusion criteria

* are suffering from any unstable medical condition precluding the use of the CO monitor (e.g. severe COPD) * are currently using smokeless tobacco including e-cigarettes * are currently using nicotine replacement therapy or other smoking cessation treatment * are pregnant, determined by participant self-report * have a negative baseline result on both urine cotinine AND CO monitor

Design outcomes

Primary

MeasureTime frameDescription
Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)baselineA point of care test for measuring carbon monoxide (CO) will be conducted via the piCO Smokerlyzer from OPS Medical, designed specifically for smoking cessation programs and tobacco control programs. Carbon monoxide will be measured in an exhaled breath in parts-per-million (ppm). A reading of ≤ 10ppm will indicate abstinence.
Number of Participants With Color Change for Urine Test for Measuring CotininebaselineA point of care urine test for measuring cotinine will also be conducted via the SmokeScreen® test from GFC Diagnostics Ltd. to verify smoking status. A color change to red/orange indicates a positive sample, with a darker color indicating greater nicotine intake.

Secondary

MeasureTime frameDescription
Reasons for Quitting ScalebaselineWe used the Reasons for Quitting (RFQ) scale to measure motivation to quit smoking. The scale is used to measure intrinsic and extrinsic motivation for quitting smoking. Each item in the scale is evaluated using a 5-point Likert scale regarding how true the statement is about the participant's motivation to quit smoking (Not at all true, a little bit true, moderately true, quite true, extremely true). Each option takes on a numerical score from 0 (not at all true) to 4 (extremely true). Scores are summed across all items in the scale and divided by the number of items in the scale to obtain the RFQ score. The range of possible scores is 0 to 4. A higher score indicates greater motivation to quit smoking.

Countries

United States

Participant flow

Recruitment details

Participants were recruited through posters advertising the study around the Johns Hopkins Medical Institutions East Baltimore campus, including clinics, inpatient and outpatient facilities, and through participant referrals.

Pre-assignment details

160 participants were assessed for eligibility, 58 did not meet inclusion criteria

Participants by arm

ArmCount
Control
A certified smoking cessation interventionist (SCI) will deliver standardized smoking cessation counseling using the National Cancer Institute (NCI) 5 A's model. Cessation counseling: The advice to quit smoking message will follow NCI's 5 A's model for smoking cessation counseling. This is a simple smoking cessation counseling strategy with 5 discrete components: (1) Ask about smoking at every opportunity; (2) Advise the patient to quit smoking; (3) Assess readiness to quit; (4) Assist the patient in quitting; and (5) Arrange follow-up.
52
COach2Quit
A certified smoking cessation interventionist (SCI) will deliver standardized smoking cessation counseling using the National Cancer Institute's 5 A's model. Participants in the COach2Quit arm will be provided with an individualized carbon monoxide (iCO) monitor along with instructions on the use of the monitor and the COach2Quit application. Individualized carbon monoxide (iCO) monitor: a personal monitor for a breath test for carbon monoxide (CO) COach2Quit smartphone application: This smartphone application works in conjunction with the iCO monitor Cessation counseling: The advice to quit smoking message will follow NCI's 5 A's model for smoking cessation counseling. This is a simple smoking cessation counseling strategy with 5 discrete components: (1) Ask about smoking at every opportunity; (2) Advise the patient to quit smoking; (3) Assess readiness to quit; (4) Assist the patient in quitting; and (5) Arrange follow-up.
50
Total102

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up211

Baseline characteristics

CharacteristicCOach2QuitTotalControl
Age, Continuous52 years52 years51 years
Cigarettes smoked per day10 cigarettes10 cigarettes10 cigarettes
Education
High school or more
30 Participants68 Participants38 Participants
Education
Less than high school
20 Participants34 Participants14 Participants
Employment
Employed (full/part time)
6 Participants19 Participants13 Participants
Employment
Unemployed/don't work
44 Participants83 Participants39 Participants
Fagerström Test for Nicotine Dependence2.54 score
STANDARD_DEVIATION 1.43
2.69 score
STANDARD_DEVIATION 1.47
2.85 score
STANDARD_DEVIATION 1.51
Quit attempts in past 12 months2 attempts2 attempts2 attempts
Race/Ethnicity, Customized
Black/African American
42 Participants81 Participants39 Participants
Race/Ethnicity, Customized
Mixed Race/Other
2 Participants5 Participants3 Participants
Race/Ethnicity, Customized
White
6 Participants16 Participants10 Participants
Region of Enrollment
United States
50 participants102 participants52 participants
Sex: Female, Male
Female
28 Participants59 Participants31 Participants
Sex: Female, Male
Male
22 Participants43 Participants21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 520 / 50
other
Total, other adverse events
0 / 520 / 50
serious
Total, serious adverse events
0 / 520 / 50

Outcome results

Primary

Number of Participants With Color Change for Urine Test for Measuring Cotinine

A point of care urine test for measuring cotinine will also be conducted via the SmokeScreen® test from GFC Diagnostics Ltd. to verify smoking status. A color change to red/orange indicates a positive sample, with a darker color indicating greater nicotine intake.

Time frame: baseline

Population: Thirteen participants were lost to follow-up (9 at the 14-day visit and 4 at the 30-day visit) and the sample size for the analysis was 89. There were no significant differences in baseline characteristics between participants lost to follow-up and participants who completed the study.

ArmMeasureGroupValue (NUMBER)
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineNormal / no change1 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineLight13 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineModerate11 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineHeavy8 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineVery Heavy12 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineMissing/could not interpret5 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineVery Heavy5 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineNormal / no change1 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineHeavy14 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineLight2 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineMissing/could not interpret4 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineModerate13 participants
Primary

Number of Participants With Color Change for Urine Test for Measuring Cotinine

A point of care urine test for measuring cotinine will also be conducted via the SmokeScreen® test from GFC Diagnostics Ltd. to verify smoking status. A color change to red/orange indicates a positive sample, with a darker color indicating greater nicotine intake.

Time frame: 1 month

Population: Thirteen participants were lost to follow-up (9 at the 14-day visit and 4 at the 30-day visit) and the sample size for the analysis was 89. There were no significant differences in baseline characteristics between participants lost to follow-up and participants who completed the study.

ArmMeasureGroupValue (NUMBER)
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineLight6 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineHeavy13 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineNormal / no change1 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineVery Heavy10 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineModerate11 participants
ControlNumber of Participants With Color Change for Urine Test for Measuring CotinineMissing/could not interpret9 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineMissing/could not interpret9 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineNormal / no change1 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineLight2 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineModerate10 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineHeavy12 participants
COach2QuitNumber of Participants With Color Change for Urine Test for Measuring CotinineVery Heavy5 participants
Primary

Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)

A point of care test for measuring carbon monoxide (CO) will be conducted via the piCO Smokerlyzer from OPS Medical, designed specifically for smoking cessation programs and tobacco control programs. Carbon monoxide will be measured in an exhaled breath in parts-per-million (ppm). A reading of ≤ 10ppm will indicate abstinence.

Time frame: baseline

Population: Thirteen participants were lost to follow-up (9 at the 14-day visit and 4 at the 30-day visit) and the sample size for the analysis was 89. There were no significant differences in baseline characteristics between participants lost to follow-up and participants who completed the study.

ArmMeasureValue (MEDIAN)
ControlSmoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)22.0 parts per million
COach2QuitSmoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)23.0 parts per million
Primary

Smoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)

A point of care test for measuring carbon monoxide (CO) will be conducted via the piCO Smokerlyzer from OPS Medical, designed specifically for smoking cessation programs and tobacco control programs. Carbon monoxide will be measured in an exhaled breath in parts-per-million (ppm). A reading of ≤ 10ppm will indicate abstinence.

Time frame: 1 month

Population: Thirteen participants were lost to follow-up (9 at the 14-day visit and 4 at the 30-day visit) and the sample size for the analysis was 89. There were no significant differences in baseline characteristics between participants lost to follow-up and participants who completed the study.

ArmMeasureValue (MEDIAN)
ControlSmoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)18.5 parts per million
COach2QuitSmoking Status Using a Point of Care Test for Measuring Carbon Monoxide (CO)19.5 parts per million
Secondary

Reasons for Quitting Scale

We used the Reasons for Quitting (RFQ) scale to measure motivation to quit smoking. The scale is used to measure intrinsic and extrinsic motivation for quitting smoking. Each item in the scale is evaluated using a 5-point Likert scale regarding how true the statement is about the participant's motivation to quit smoking (Not at all true, a little bit true, moderately true, quite true, extremely true). Each option takes on a numerical score from 0 (not at all true) to 4 (extremely true). Scores are summed across all items in the scale and divided by the number of items in the scale to obtain the RFQ score. The range of possible scores is 0 to 4. A higher score indicates greater motivation to quit smoking.

Time frame: baseline

Population: Thirteen participants were lost to follow-up (9 at the 14-day visit and 4 at the 30-day visit) and the sample size for the analysis was 89. There were no significant differences in baseline characteristics between participants lost to follow-up and participants who completed the study.

ArmMeasureValue (MEAN)
ControlReasons for Quitting Scale2.6 score on a scale
COach2QuitReasons for Quitting Scale2.6 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026